IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CLGN

Balance Sheet

(in millions USD)
MetricQ1 2025Q2 2024Q2 2023Q2 2022Q2 2021
Cash & Equivalents--18.9222.2836.2917.49
Accounts Receivable--0.2510.160.010.28
Inventory--0.441.551.360.94
Total Current Assets--20.3434.8638.2749.77
Property, Plant & Equipment--2.562.932.932.12
Intangible Assets--0.160.220.240.16
Total Non-current Assets--6.236.716.145.25
Total Assets--26.5741.5744.4155.02
Total Current Liabilities--3.242.782.362.93
Total Non-current Liabilities--2.602.752.552.65
Total Liabilities--5.845.534.915.58
Retained Earnings--(105.15)(87.67)(80.94)(65.95)
Total Stockholder Equity12.4020.7336.0439.5149.44
← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Total Revenue0.180.2510.180.070.69
Cost of Revenue0.190.540.620.040.43
Gross Profit(0.01)(0.29)9.570.020.26
Research & Development2.012.702.572.601.90
Selling, General & Admin1.161.421.321.611.42
Total Operating Expenses3.174.127.524.213.33
Operating Income(3.18)(4.41)5.68(4.18)(3.06)
Net Income(3.35)(4.21)5.76(4.28)(3.04)
Basic EPS0.28(0.37)0.51(0.39)--
Diluted EPS0.28(0.37)0.49(0.39)--
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2024Q2 2023Q2 2022Q2 2021
Operating Cash Flow(7.18)(7.19)--7.74
Capital Expenditures0.280.480.680.37
Free Cash Flow*(7.46)(7.68)--7.37
Investing Cash Flow(0.34)(0.54)29.55(30.45)
Financing Cash Flow0.010.891.4736.87
← Scroll for more columns →

* Derived from reported values